Cardiothoracic & vascular anesthesia

Association of postoperative haemoglobin with adverse outcomes in patients undergoing cardiac surgery: a retrospective single centre cohort study

BJA OpenPublished Retrospective cohort study

Authors' conclusion

In postoperative cardiac surgical patients, progressive decreases in postoperative haemoglobin are associated with increased risk of mortality and major morbidity at 30 days.

Study context

Population
Adults (≥18 yr) undergoing coronary revascularisation, valve surgery, or a combination at Toronto General Hospital, 2016–2020
Participants
5,960 adults
Exposure
POD1 haemoglobin ≤80 g L-1 vs >80 g L-1, and per 10 g L-1 decrease
  • Haemoglobin ≤80 g L-1n = 1,794
Outcome
Composite of:
  • Mortality
  • Stroke
  • MI
  • AKI
  • Sternal wound infection
  • A combination
Follow-up
30 days
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Primary composite outcome
Adjusted odds ratio (CI)P value
Each 10 g L-1 decrease in POD1 haemoglobin
1.15(1.05–1.25)
P < 0.001
Haemoglobin ≤80 g L-1 vs Haemoglobin >80 g L-1
1.44(1.19–1.75)
P < 0.001

Observational data: associations, not effects.

Secondary outcomes

OutcomeAdjusted IRR (CI)P value
Incidence of adverse eventsEach 10 g L-1 decrease in haemoglobin · Poisson regression; adjusted for clustering and confounders1.14 (1.07–1.20)P < 0.001

Incidence of adverse events

Adjusted IRR (CI)P value
Haemoglobin <80 g L-1Poisson regression; adjusted for clustering and confounders1.33 (1.16–1.54)P < 0.001

RBC transfusion

Transfused, whole cohort
49%
Transfused, POD1 haemoglobin ≤80 g L-1
90%

Original publication

Association of postoperative haemoglobin with adverse outcomes in patients undergoing cardiac surgery: a retrospective single centre cohort study. BJA Open. Published 17 December 2025. doi:10.1016/j.bjao.2025.100508

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.